Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2022 Mar 22:ciac219. doi: 10.1093/cid/ciac219

Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission

Oon Tek Ng 1,2,3,, Vanessa Koh 4,5, Calvin J Chiew 6, Kalisvar Marimuthu 7,8,9, Natascha May Thevasagayam 10,11, Tze Minn Mak 12, Joon Kiat Chua 13, Shannen Si Hui Ong 14, Yong Kai Lim 15, Zannatul Ferdous 16,17, Alifa Khairunnisa bte Johari 18,19, Lin Cui 20, Raymond Tzer Pin Lin 21,22, Kelvin Bryan Tan 23,24,25, Alex R Cook 26, Yee-Sin Leo 27,28,29,30,31, Vernon J M Lee 32,33
PMCID: PMC9129132  PMID: 35323887

Abstract

Background

The impact of SARS-CoV-2 vaccination status and paediatric age on transmission of the Delta variant is key to preventing COVID-19 spread. In Singapore, quarantine of all close-contacts, and quarantine-entry and exit PCR testing, enabled evaluation of these factors.

Methods

This retrospective cohort study included all household close-contacts between March 1, 2021 and August 31, 2021. Logistic regression using generalized estimating equations was used to determine risk factors associated with SARS-CoV-2 acquisition and symptomatic disease.

Findings

Among 8470 Delta variant-exposed household close-contacts linked to 2583 indices, full-vaccination of the index with BNT162b2 or mRNA-1273 was associated with significant reduction in SARS-CoV-2 acquisition by contacts (adjusted odds ratio [aOR]:0.56, 95% robust confidence interval [RCI]:0.44–0.71 and aOR:0.51, 95%RCI:0.27–0.96 respectively).

Compared to young adults (18–29y), children (0–11y) were significantly more likely to transmit (aOR:2.37 [95%RCI:1.57–3.60]) and acquire (aOR:1.43 [95%RCI:1.07–1.93]) infection, taking into account vaccination status.

Longer duration from completion of vaccination among contacts was associated with decline in protection against acquisition (first-month aOR:0.42, 95%RCI:0.33–0.55; fifth-month aOR:0.84, 95%RCI:0.55–0.98; p<0.0001 for trend) and symptomatic disease (first-month aOR:0.30, 95%RCI:0.23–0.41; fifth-month aOR;0.62, 95%RCI:0.38–1.02; p<0.0001 for trend). Contacts immunized with mRNA-1273 had significant reduction in acquisition (aOR:0.73, 95%RCI:0.58–0.91) compared to BNT162b2.

Conclusions

Among household close-contacts, vaccination prevented onward SARS-CoV-2 transmission and there was increased risk of SARS-CoV-2 acquisition and transmission among children compared with young adults. Time after completion of vaccination and vaccine type affected SARS-CoV-2 acquisition.

Keywords: SARS-CoV-2, COVID-19, Vaccination, Delta Variant, Transmission

Contributor Information

Oon Tek Ng, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Vanessa Koh, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.

Calvin J Chiew, Communicable Diseases Division, Ministry of Health, Singapore.

Kalisvar Marimuthu, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Natascha May Thevasagayam, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.

Tze Minn Mak, National Centre for Infectious Diseases, Singapore.

Joon Kiat Chua, Ministry of Health, Singapore.

Shannen Si Hui Ong, Ministry of Health, Singapore.

Yong Kai Lim, Ministry of Health, Singapore.

Zannatul Ferdous, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.

Alifa Khairunnisa bte Johari, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore.

Lin Cui, National Centre for Infectious Diseases, Singapore.

Raymond Tzer Pin Lin, National Centre for Infectious Diseases, Singapore; Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Kelvin Bryan Tan, Ministry of Health, Singapore; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Centre for Regulatory Excellence, Duke-NUS Medical School.

Alex R Cook, Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.

Prof Yee-Sin Leo, National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore; Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore.

Prof Vernon J M Lee, Communicable Diseases Division, Ministry of Health, Singapore; Saw Swee Hock School of Public Health, Singapore.

Supplementary Material

ciac219_suppl_Supplementary_Appendix

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ciac219_suppl_Supplementary_Appendix

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES